Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Acquisitions & Divestments (2021 - 2023)

Historic Change in Acquisitions & Divestments for InspireMD (NSPR) over the last 3 years, with Q3 2023 value amounting to $6.5 million.

  • InspireMD's Change in Acquisitions & Divestments fell 3500.0% to $6.5 million in Q3 2023 from the same period last year, while for Dec 2023 it was $18.5 million, marking a year-over-year decrease of 3392.86%. This contributed to the annual value of $18.5 million for FY2023, which is 3392.86% down from last year.
  • As of Q3 2023, InspireMD's Change in Acquisitions & Divestments stood at $6.5 million, which was down 3500.0% from $5.0 million recorded in Q2 2023.
  • In the past 5 years, InspireMD's Change in Acquisitions & Divestments registered a high of $10.0 million during Q3 2022, and its lowest value of -$22.0 million during Q4 2021.
  • Its 3-year average for Change in Acquisitions & Divestments is $3.1 million, with a median of $6.0 million in 2022.
  • In the last 5 years, InspireMD's Change in Acquisitions & Divestments skyrocketed by 12727.27% in 2022 and then plummeted by 3500.0% in 2023.
  • InspireMD's Change in Acquisitions & Divestments (Quarter) stood at -$22.0 million in 2021, then soared by 127.27% to $6.0 million in 2022, then increased by 8.33% to $6.5 million in 2023.
  • Its Change in Acquisitions & Divestments stands at $6.5 million for Q3 2023, versus $5.0 million for Q2 2023 and $7.0 million for Q1 2023.